
Omar Casillashernandez
Examiner (ID: 12919, Phone: (571)270-5432 , Office: P/2689 )
| Most Active Art Unit | 2689 |
| Art Unit(s) | 2689 |
| Total Applications | 789 |
| Issued Applications | 579 |
| Pending Applications | 71 |
| Abandoned Applications | 147 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15898427
[patent_doc_number] => 20200148732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => SMALL MOLECULES BLOCKING HISTONE READER DOMAINS
[patent_app_type] => utility
[patent_app_number] => 16/699435
[patent_app_country] => US
[patent_app_date] => 2019-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16699435
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/699435 | Small molecules blocking histone reader domains | Nov 28, 2019 | Issued |
Array
(
[id] => 17343628
[patent_doc_number] => 20220009959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PEPTIDE LIGANDS FOR CAPTURE OF HOST CELL PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/296795
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/296795 | PEPTIDE LIGANDS FOR CAPTURE OF HOST CELL PROTEINS | Nov 25, 2019 | Pending |
Array
(
[id] => 18932342
[patent_doc_number] => 11884749
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Compositions and methods for treating endometriosis
[patent_app_type] => utility
[patent_app_number] => 17/295377
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 28272
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295377
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/295377 | Compositions and methods for treating endometriosis | Nov 20, 2019 | Issued |
Array
(
[id] => 16499940
[patent_doc_number] => 10865316
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Conotoxin peptides for use in biofouling deterrence
[patent_app_type] => utility
[patent_app_number] => 16/685101
[patent_app_country] => US
[patent_app_date] => 2019-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7473
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16685101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/685101 | Conotoxin peptides for use in biofouling deterrence | Nov 14, 2019 | Issued |
Array
(
[id] => 15931811
[patent_doc_number] => 20200157539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => USE OF THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/681416
[patent_app_country] => US
[patent_app_date] => 2019-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16681416
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/681416 | Use of therapeutic agents | Nov 11, 2019 | Issued |
Array
(
[id] => 17546710
[patent_doc_number] => 20220118051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => SELF-ASSEMBLING VEGF NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/292265
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14360
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292265 | SELF-ASSEMBLING VEGF NANOPARTICLES | Nov 7, 2019 | Pending |
Array
(
[id] => 18213411
[patent_doc_number] => 20230059675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => TUMOR-SPECIFIC POLYPEPTIDE SEQUENCE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/774873
[patent_app_country] => US
[patent_app_date] => 2019-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774873
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/774873 | Tumor-specific polypeptide sequence and use thereof | Nov 6, 2019 | Issued |
Array
(
[id] => 18428730
[patent_doc_number] => 11673940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Recombinant production of a collagen peptide preparation and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/287905
[patent_app_country] => US
[patent_app_date] => 2019-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 15952
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17287905
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/287905 | Recombinant production of a collagen peptide preparation and use thereof | Nov 5, 2019 | Issued |
Array
(
[id] => 15828619
[patent_doc_number] => 20200129591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => COMPOSITION HAVING TISSUE-REPAIRING ACTIVITY, AND USE THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/671497
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16671497
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/671497 | Composition having tissue-repairing activity, and use therefor | Oct 31, 2019 | Issued |
Array
(
[id] => 15589687
[patent_doc_number] => 20200071378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => VSIG8-BASED CHIMERIC PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/665803
[patent_app_country] => US
[patent_app_date] => 2019-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16665803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/665803 | VSIG8-based chimeric proteins | Oct 27, 2019 | Issued |
Array
(
[id] => 15451295
[patent_doc_number] => 20200038471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/661036
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16661036
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/661036 | SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS | Oct 22, 2019 | Abandoned |
Array
(
[id] => 17458783
[patent_doc_number] => 20220072087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => SPECIFIC COMBINATION THERAPY FOR TREATMENT OF PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 17/422786
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/422786 | SPECIFIC COMBINATION THERAPY FOR TREATMENT OF PANCREATIC CANCER | Oct 16, 2019 | Abandoned |
Array
(
[id] => 17890747
[patent_doc_number] => 11453700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Peptide having activities of skin whitening and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/625841
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 4
[patent_no_of_words] => 4018
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625841 | Peptide having activities of skin whitening and uses thereof | Oct 9, 2019 | Issued |
Array
(
[id] => 17336014
[patent_doc_number] => 20220002345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => Bone-Targeting Therapeutic Compositions and Methods of Using Them
[patent_app_type] => utility
[patent_app_number] => 17/283312
[patent_app_country] => US
[patent_app_date] => 2019-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283312 | Bone-Targeting Therapeutic Compositions and Methods of Using Them | Oct 7, 2019 | Abandoned |
Array
(
[id] => 19367390
[patent_doc_number] => 12059450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-13
[patent_title] => Anticancer pharmaceutical composition containing IF1 as active ingredient
[patent_app_type] => utility
[patent_app_number] => 17/281808
[patent_app_country] => US
[patent_app_date] => 2019-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 6174
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/281808 | Anticancer pharmaceutical composition containing IF1 as active ingredient | Oct 1, 2019 | Issued |
Array
(
[id] => 16191109
[patent_doc_number] => 20200231958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 16/589851
[patent_app_country] => US
[patent_app_date] => 2019-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16589851
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/589851 | FACTOR IX POLYPEPTIDE MUTANT, ITS USES AND A METHOD FOR ITS PRODUCTION | Sep 30, 2019 | Abandoned |
Array
(
[id] => 17426065
[patent_doc_number] => 20220053773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOGENIC INFECTIONS IN PLANTS
[patent_app_type] => utility
[patent_app_number] => 17/281884
[patent_app_country] => US
[patent_app_date] => 2019-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17281884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/281884 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOGENIC INFECTIONS IN PLANTS | Sep 30, 2019 | Pending |
Array
(
[id] => 15361495
[patent_doc_number] => 20200016512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => AFFINITY SEPARATION MATRIX FOR PURIFYING IMMUNOGLOBULIN
[patent_app_type] => utility
[patent_app_number] => 16/586054
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16586054
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/586054 | AFFINITY SEPARATION MATRIX FOR PURIFYING IMMUNOGLOBULIN | Sep 26, 2019 | Abandoned |
Array
(
[id] => 20621654
[patent_doc_number] => 12589148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-31
[patent_title] => Immunity-inducing agent comprising antigen peptide-adjuvant nucleotide conjugate and pharmaceutical composition comprising same
[patent_app_type] => utility
[patent_app_number] => 17/280605
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 6896
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280605
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/280605 | Immunity-inducing agent comprising antigen peptide-adjuvant nucleotide conjugate and pharmaceutical composition comprising same | Sep 26, 2019 | Issued |
Array
(
[id] => 17198493
[patent_doc_number] => 20210338587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => INJECTABLE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/279807
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279807
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/279807 | INJECTABLE COMPOSITION | Sep 26, 2019 | Pending |